11 analysts have shared their evaluations of Elevance Health (NYSE:ELV) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $573.91, a high estimate of $622.00, and a low estimate of $478.00. A 4.8% drop is evident in the current average compared to the previous average price target of $…